| Net Cash Provided by (Used in) Operating Activities |
$-103,000 |
USD |
60% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$124,000 |
USD |
-72.81% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$-1,000 |
USD |
98% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
900,000,000 |
shares |
0% |
Q4 2024 |
FY 2024 |
| Common Stock, Shares, Issued |
521,133,474 |
shares |
58% |
Q4 2024 |
FY 2024 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$16,000 |
USD |
-89.47% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$379,000 |
USD |
56% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Gross |
$379,000 |
USD |
56% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$379,000 |
USD |
56% |
Q4 2024 |
FY 2024 |
| Unrecognized Tax Benefits |
$20,000 |
USD |
|
Q4 2024 |
FY 2024 |
| Additional Paid in Capital |
$7,043,000 |
USD |
31% |
Q3 2025 |
Q3 2025 |
| Depreciation, Depletion and Amortization |
$6,000 |
USD |
0% |
Q1 2024 |
Q1 2024 |
| Share-based Payment Arrangement, Expense |
$-43,000 |
USD |
-137.07% |
Q1 2025 |
Q1 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |